RICTOR expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.257800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.275400E-01
Normal-vs-Stage2
4.324000E-01
Normal-vs-Stage3
2.571200E-01
Normal-vs-Stage4
3.074800E-01
Stage1-vs-Stage2
5.248600E-01
Stage1-vs-Stage3
2.985700E-02
Stage1-vs-Stage4
4.931800E-01
Stage2-vs-Stage3
1.081210E-01
Stage2-vs-Stage4
8.648000E-01
Stage3-vs-Stage4
1.860630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.196000E-01
Normal-vs-AfricanAmerican
3.424600E-01
Normal-vs-Asian
2.035800E-01
Caucasian-vs-AfricanAmerican
5.284000E-01
Caucasian-vs-Asian
8.390000E-01
AfricanAmerican-vs-Asian
7.321800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.264000E-01
Normal-vs-Female
4.295000E-01
Male-vs-Female
9.459600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.649800E-01
Normal-vs-Age(41-60Yrs)
5.316400E-01
Normal-vs-Age(61-80Yrs)
3.958400E-01
Normal-vs-Age(81-100Yrs)
3.103600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.266600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.052400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.861440E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.260160E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.816500E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.293400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.742600E-01
Normal-vs-Daily Drinker
3.925400E-01
Normal-vs-Weekly Drinker
5.881700E-02
Normal-vs-Occasional Drinker
2.199000E-01
Normal-vs-Social Drinker
4.906000E-01
Non Drinker-vs-Daily Drinker
8.204800E-01
Non Drinker-vs-Weekly Drinker
6.131000E-01
Non Drinker-vs-Occasional Drinker
7.300400E-02
Non Drinker-vs-Social Drinker
1.776830E-01
Daily Drinker-vs-Weekly Drinker
5.580400E-01
Daily Drinker-vs-Occasional Drinker
1.840200E-01
Daily Drinker-vs-Social Drinker
3.451600E-01
Weekly Drinker-vs-Occasional Drinker
8.727500E-02
Weekly Drinker-vs-Social Drinker
1.598430E-01
Occasional Drinker-vs-Social Drinker
7.164800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.439790E-01
Normal-vs-Grade 2
2.679500E-02
Normal-vs-Grade 3
1.101610E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.626800E-01
Grade 1-vs-Grade 3
5.382200E-01
Grade 1-vs-Grade 4
1.439790E-01
Grade 2-vs-Grade 3
1.689040E-01
Grade 2-vs-Grade 4
2.679500E-02
Grade 3-vs-Grade 4
1.101610E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.655000E-01
Normal-vs-NonDiabetic
4.190600E-01
Diabetic-vs-NonDiabetic
2.700200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.176400E-01
Normal-vs-NoPancreatitis
4.080200E-01
Pancreatitis-vs-NoPancreatitis
9.478200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.213400E-01
Normal-vs-N1
4.250600E-01
N0-vs-N1
9.121400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.379200E-01
Normal-vs-TP53-NonMutant
4.867400E-01
TP53-Mutant-vs-TP53-NonMutant
4.950200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
